HydroWhirl S tank cleaning nozzle now ATEX certified

Published: 28-Feb-2012
Manufacturing Cleaning Pharmaceutical Active Nutrition Food

For use in atmospheres that are potentially explosive

The HydroWhirl S tank washing nozzle range from BETE has recently been expanded to include ATEX certified versions for use in atmospheres that are potentially explosive.

The HydroWhirl is designed to meet the exacting standards for effective cleaning-in-place (CIP) required in the pharmaceutical, chemical, food, dairy and beverage industries. As well as being certified for use in potentially explosive areas, the ATEX certified nozzles also meet the requirements for gas and dust approvals for all zones (0,1 and 2).

HydroWhirl nozzles are self-cleaning and self-lubricating, which eliminates the possibility of process contamination, while its compact design allows it to be fitted through small, restricted access flanges. They are ideal for medium tanks (up to 5 metres in diameter), used in the pharmaceutical and chemical, food and petrochemical industries, where superior cleaning combined with reduced cycle times, lower water, energy and chemical consumption are increasingly becoming important considerations.

See more

You may also like

Manufacturing

Faster tank cleaning with PTFE nozzle

Read more
HydroWhirl Poseidon removes scum rings and tougher residues

Trending Articles

  1. Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region
  2. The IND advantage: why early derisking is a strategic imperative for complex biologics As biologics grow more complex, early identification and the mitigation of manufacturability, stability and immunogenicity risks have become the critical factor separating programmes that reach IND on time from those that don't, says Yvette Stallwood, Head of Early Development Services at Lonza
  3. AI-designed drug product enters clinical development Phase I study of an AI-designed oral formulation sets a new standard in drug development
  4. Cutting-edge wiped film evaporator installation – non-tobacco nicotine products Successful system installation for a UK research and development facility developing and commercialising non-tobacco nicotine products using industry-leading evaporation equipment
  5. Nestlé Health Science and IdB partner to bring VOWST to Europe Nestlé Health Science and IdB Holding have signed a licensing agreement to seek EMA approval for VOWST, the only FDA-approved oral live biotherapeutic for recurrent C. diff prevention

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

You may also like

Manufacturing

Faster tank cleaning with PTFE nozzle

HydroWhirl Poseidon removes scum rings and tougher residues
Cleaning

Bete introduces high impact rotary tank cleaner

HydroWhirl Orbiter meets exacting cleaning standards
Manufacturing

Lonza appoints Hans Trees as Global Head of Communications

Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Ingredients

Safe and accurate flow measurement for pharmaceutical production

Oval Gear (OG) meters from Titan Enterprises, fitted with a Namur sensor, provide consistent, accurate measurement across a wide range of liquids, from low-viscosity solvents to more viscous pharmaceutical ingredients
Manufacturing

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Research & Development

The IND advantage: why early derisking is a strategic imperative for complex biologics

As biologics grow more complex, early identification and the mitigation of manufacturability, stability and immunogenicity risks have become the critical factor separating programmes that reach IND on time from those that don't, says Yvette Stallwood, Head of Early Development Services at Lonza
Subscribe now